Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity

Overview of attention for article published in Journal for Immunotherapy of Cancer, April 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 12 X users

Readers on

mendeley: 83 Mendeley

Summary X

So far, Altmetric has seen 21 X posts from 12 X users, with an upper bound of 36,085 followers.

RT @sitcancer: #JITC Research: Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases:…

13 Dec 2021

Reply Repost Favourite

RT @gminniti2012: Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation o…

13 Dec 2021

Reply Repost Favourite

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity https://t.co/jDfHOwxFf8

04 Jan 2021

Reply Repost Favourite

RT @gminniti2012: Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation o…

04 Jan 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 17 additional X posts.